Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

Completed · Phase 2

Conditions studied: Brain and Central Nervous System Tumors

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and combining chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation may allow doctors to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus bone marrow transplantation or peripheral stem cell transplantation in treating patients who have oligodendroglioma.

Key facts

Study ID

NCT00003101

Run by

Memorial Sloan Kettering Cancer Center

People needed

60

Starts

1997-08-01

Expected to finish

2002-01-01

Last updated by the study team

2013-06-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Alabama Comprehensive Cancer Center — Birmingham, Alabama, United States
• Stanford University Medical Center — Stanford, California, United States
• Evanston Northwestern Health Care — Evanston, Illinois, United States
• Loyola University Medical Center — Maywood, Illinois, United States
• Memorial Sloan-Kettering Cancer Center — New York, New York, United States
• Tom Baker Cancer Center - Calgary — Calgary, Alberta, Canada
• Cancer Care Ontario-London Regional Cancer Centre — London, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.